Asterias Biotherapeutics, Inc.·4

Feb 18, 8:58 PM ET

Asterias Biotherapeutics, Inc. 4

4 · Asterias Biotherapeutics, Inc. · Filed Feb 18, 2015

Insider Transaction Report

Form 4
Period: 2015-02-13
LEBKOWSKI JANE
Pres., Research & Development
Transactions
  • Award

    Stock Option (right to buy)

    2015-02-13+100,000100,000 total
    Exercise: $3.90Exp: 2025-02-12Series A Common Stock (100,000 underlying)
  • Award

    Restricted Stock Units

    2015-02-13+31,02531,025 total
    Series A Common Stock (31,025 underlying)
Footnotes (3)
  • [F1]These options will vest and become exercisable in 48 equal monthly installments beginning on the one month anniversary of the date of grant.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of AST Series A Common Stock.
  • [F3]These restricted stock units vest in four equal quarterly installments beginning June 30, 2015.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION